June 3, 2014| Premia Spine, formerly known as Impliant, announced this week that it was able to raise $7 million of its $10 million financing goal for the development of its artificial lumbar plates for the spine. According to Globes, the company, which is active in the UK, Germany, Austria, Italy and Israel, has already made NIS 5-8 million in sales after only two years on the market. Although not currently available in the United States, Premia Spine hopes to use recent investments to seal American marketing approval and begin sales there.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments